Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials

The effect of five approved tumour necrosis factor inhibitors (TNFi: infliximab, etanercept, adalimumab, certolizumab, and golimumab) on joint destruction in rheumatoid arthritis (RA) have been compared versus methotrexate (MTX) in randomized controlled trials (RCTs) but have not been compared direc...

Descripción completa

Detalles Bibliográficos
Autores principales: Graudal, Niels, Kaas-Hansen, Benjamin Skov, Guski, Louise, Hubeck-Graudal, Thorbjørn, Welton, Nicky J., Jürgens, Gesche
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770755/
https://www.ncbi.nlm.nih.gov/pubmed/31491879
http://dx.doi.org/10.3390/ijms20184350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770755/
https://www.ncbi.nlm.nih.gov/pubmed/31491879
http://dx.doi.org/10.3390/ijms20184350

Ejemplares similares